IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJV11I5A116

CoreValve Evolut R implantation as valve-in-valve in an Edwards SAPIEN 3 to treat paravalvular regurgitation

Giuseppe Bruschi1*, MD; Francesco Soriano1, MD; Francesco Musca1, MD; Stefano Nava1, MD; Arturo Einaudi2, MD; Andrea Garascia1, MD; Oriana Belli1, MD; Alberto Barosi1, MD; Pasquale Fratto1, MD; Paola Colombo1, MD, PhD; Claudio Francesco Russo1, MD; Maria Pia Gagliardone2, MD; Silvio Klugmann1, MD

A 75-year-old male underwent transfemoral transcatheter aortic valve implantation (TAVI) with a 23 mm SAPIEN 3 (Edwards Lifesciences Inc., Irvine, CA, USA). One year after, he was admitted to our department for pulmonary oedema. Echocardiographic evaluation evidenced low placement of the SAPIEN 3 and 3-(4)+/4+ aortic regurgitation. ECG-gated multislice computed tomography (MSCT) was performed which confirmed low placement (Moving image 1) and underexpansion of the SAPIEN 3 with a perimeter of 62 mm and diameter of 20 mm (Figure 1A-Figure 1C). After Heart Team evaluation, a new TAVI procedure was preferred with the implantation of a 26 mm CoreValve® Evolut R™ (Medtronic, Minneapolis, MN, USA). Basal aortography evidenced significant paravalvular regurgitation (Moving image 2). Haemodynamic evaluation revealed a mean aortic gradient of 25 mmHg and an aortic regurgitation index of 22. After 26 mm Evolut R implantation, post-dilatation was performed. Final aortography showed trivial paravalvular regurgitation (Moving image 3). Haemodynamic assessment evidenced a mean transaortic gradient of 4 mmHg and an aortic regurgitation index of 44. Pre-discharge ECG-gated MSCT evidenced good Evolut R expansion inside the SAPIEN 3 (Figure 1D) and echocardiography showed trivial paravalvular regurgitation (Moving image 4).

Figure 1. SAPIEN 3 ECG-gated multislice computed tomography evaluation and final results after valve-in-valve with CoreValve Evolut R. A) MSCT oblique coronal view that evidenced low SAPIEN 3 implantation and underexpansion with a valve diameter of 19.8 mm. B) Double oblique transverse reformatting of the annulus on MSCT with SAPIEN 3 area of 300 mm2 and perimeter of 62 mm. C) 3D MSCT evidenced low placement of the 23 mm SAPIEN 3 valve. D) 3D MSCT evidenced full Evolut R expansion inside the SAPIEN 3 valve.

Implantation of a CoreValve Evolut R prosthesis for the treatment of a dysfunctioning Edwards SAPIEN 3 prosthesis is feasible and is associated with a good functional result.

Conflict of interest statement

G. Bruschi is a consultant for Medtronic and Direct Flow Medical. The other authors have no conflicts of interest to declare.

Online data supplement

Moving image 1. 3D reconstruction of multislice computed tomography that evidenced low placement of the SAPIEN 3 valve.

Moving image 2. Basal aortography evidenced significant paravalvular regurgitation of the SAPIEN 3 valve.

Moving image 3. Final aortography showed trivial paravalvular regurgitation with good Evolut R expansion inside the SAPIEN 3 valve.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. 3D reconstruction of multislice computed tomography that evidenced low placement of the SAPIEN 3 valve.

Moving image 2. Basal aortography evidenced significant paravalvular regurgitation of the SAPIEN 3 valve.

Moving image 3. Final aortography showed trivial paravalvular regurgitation with good Evolut R expansion inside the SAPIEN 3 valve.

Moving image 4: Final aortography shown trivial para-valvular regurgitation with good Evolut R expansion inside the Sapien 3

Volume 11 Number 5
Sep 22, 2015
Volume 11 Number 5
View full issue


Key metrics

Suggested by Cory

IMAGE IN CARDIOLOGY

10.4244/EIJV11I11A255 Feb 12, 2016
Edwards SAPIEN 3 implanted in a failing aortic bioprosthesis: first report
Molina-Martin de Nicolas J et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJY15M02_06 Jul 20, 2015
Transcatheter Lotus valve implantation in a regurgitant SAPIEN 3 valve
Van Mieghem NM et al
free

10.4244/EIJV8SQA15 Sep 30, 2012
Edwards SAPIEN 3 valve
Binder R et al
free

Original Research

10.4244/EIJ-D-24-00619 Nov 18, 2024
Redo-TAVI with the SAPIEN 3 valve in degenerated calcified CoreValve/Evolut explants
Meier D et al

CLINICAL RESEARCH

10.4244/EIJV12I2A37 Jun 10, 2016
Thirty-day outcomes in patients at intermediate risk for surgery from the SAPIEN 3 European approval trial
Vahanian A et al
free
Trending articles
200.45

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
92.95

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
51.15

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
36.5

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
33.8

Translational research

10.4244/EIJ-D-23-00308 Nov 17, 2023
Redo-TAVI with SAPIEN 3 in SAPIEN XT or SAPIEN 3 – impact of pre- and post-dilatation on final THV expansion
Meier D et al
free
22.55

CLINICAL RESEARCH

10.4244/EIJV12I5A93 Aug 5, 2016
Longer pre-hospital delays and higher mortality in women with STEMI: the e-MUST Registry
Benamer H et al
free
22.55

INTERVENTIONAL FLASHLIGHT

10.4244/EIJ-D-17-00774 Oct 19, 2018
Ultra-low contrast percutaneous coronary intervention in patients with severe chronic kidney disease
Azzalini L et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved